<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39380032</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2047-2994</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Antimicrobial resistance and infection control</Title><ISOAbbreviation>Antimicrob Resist Infect Control</ISOAbbreviation></Journal><ArticleTitle>Can probiotics trigger a paradigm shift for cleaning healthcare environments? A narrative review.</ArticleTitle><Pagination><StartPage>119</StartPage><MedlinePgn>119</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">119</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13756-024-01474-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The environment of healthcare institutions plays a major role in the transmission of multidrug resistant organisms (MDRO) and likely in subsequent healthcare-associated infections (HAIs). Probiotic cleaning products are a novel option for environmental cleaning. They represent a sustainable and biodegradable alternative to conventional chemical disinfectants for controlling microbial bioburden, and preventing pathogen transmission in hospital environments. High-quality studies including randomized clinical trials (RCT) triggered a summary with expert recommendations until further studies allow a critical review and meta-analysis of the data.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Infection control experts from five European countries summarized available data as of June 2023. Authors presented their published RCTs, reviewed the existing literature on probiotic cleaning, summarized the results and identified knowledge gaps and subsequent research needs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Probiotic cleaning was similarly effective for reducing HAI-related pathogens, enveloped viruses such as SARS-CoV-2 and MDRO in environmental samples compared to conventional chemical disinfectants. More importantly, probiotic cleaning was non-inferior to disinfectants in terms of preventing HAI in a large RCT. In addition, probiotic cleaning has also been shown to reduce antimicrobial resistance genes (ARG), costs and antimicrobial consumption in other hospital trials. They are biodegradable, do not require any protection for chemical hazards, and are compliant with occupational health. A paradigm shift, however, requires a very strong evidence to justify for such a change. In the past, this evidence was limited by the heterogeneity of study design, products, protocols, and few studies on clinical outcomes used in the trials. Furthermore, the regulatory, safety, and quality aspects of probiotic cleaning products are not, yet, completely defined and require clearing by authorities.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">To date, probiotic cleaning is a breakthrough technology and a biological alternative for chemical disinfectant when treating hospital environment. It may also have a positive effect on MDRO transmission. However, the different compositions of probiotic products will require standardization, and more robust data should be generated to support these promising results on different compositions. This may trigger a paradigm shift in cleaning of healthcare institutions from chemical to biological control of the hospital environment.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Denkel</LastName><ForeName>Luisa A</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0000-0003-4005-1315</Identifier><AffiliationInfo><Affiliation>Institute of Hygiene and Environmental Medicine, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Hindenburgdamm 27, 12203, Berlin, Germany. luisa.denkel@charite.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Reference Center for the Surveillance of Nosocomial Infections, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany. luisa.denkel@charite.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voss</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Infection Control, University Medical Center Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caselli</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Section of Microbiology, Department of Chemical, Pharmaceutical, and Agricultural Sciences, University of Ferrara, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dancer</LastName><ForeName>Stephanie J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>NHS Lanarkshire &amp; Edinburgh Napier University, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leistner</LastName><ForeName>Rasmus</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Hygiene and Environmental Medicine, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Hindenburgdamm 27, 12203, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Reference Center for the Surveillance of Nosocomial Infections, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gastmeier</LastName><ForeName>Petra</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Hygiene and Environmental Medicine, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Hindenburgdamm 27, 12203, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Reference Center for the Surveillance of Nosocomial Infections, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Widmer</LastName><ForeName>Andreas F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swissnoso - Swiss National Center for Infection Prevention, Bern, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Antimicrob Resist Infect Control</MedlineTA><NlmUniqueID>101585411</NlmUniqueID><ISSNLinking>2047-2994</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004202">Disinfectants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019936" MajorTopicYN="Y">Probiotics</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003428" MajorTopicYN="Y">Cross Infection</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017053" MajorTopicYN="N">Infection Control</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004203" MajorTopicYN="N">Disinfection</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004202" MajorTopicYN="N">Disinfectants</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006268" MajorTopicYN="N">Health Facilities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antimicrobial resistance genes (ARG)</Keyword><Keyword MajorTopicYN="N">Cleaning, healthcare-associated infections (HAI)</Keyword><Keyword MajorTopicYN="N">Expert recommendations</Keyword><Keyword MajorTopicYN="N">Probiotics</Keyword></KeywordList><CoiStatement>Conflicts of interest to declare: This workshop was financially supported by Chrisal / Heiq. LAD and AW are members of the editorial board of the journal Antimicrobial Resistance &amp; Infection Control. On behalf of all authors, the corresponding author states that there are no further conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>7</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>23</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39380032</ArticleId><ArticleId IdType="pmc">PMC11462747</ArticleId><ArticleId IdType="doi">10.1186/s13756-024-01474-6</ArticleId><ArticleId IdType="pii">10.1186/s13756-024-01474-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hu J, Shuai W, Sumner JT, Moghadam AA, Hartmann EM. Clinically relevant pathogens on surfaces display differences in survival and transcriptomic response in relation to probiotic and traditional cleaning strategies. NPJ Biofilms Microbiomes. 2022;8(1):72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9485146</ArticleId><ArticleId IdType="pubmed">36123373</ArticleId></ArticleIdList></Reference><Reference><Citation>Pittet D, Hugonnet S, Harbarth S, Mourouga P, Sauvan V, Touveneau S, Perneger TV. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infect Control Programme Lancet. 2000;356(9238):1307–12.</Citation><ArticleIdList><ArticleId IdType="pubmed">11073019</ArticleId></ArticleIdList></Reference><Reference><Citation>Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20(Suppl 1):1–55.</Citation><ArticleIdList><ArticleId IdType="pubmed">24329732</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansom SE, Gussin GM, Schoeny M, Singh RD, Adil H, Bell P, et al. Rapid Environmental Contamination with Candida Auris and Multidrug-resistant bacterial pathogens near colonized patients. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America; 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11093678</ArticleId><ArticleId IdType="pubmed">38059527</ArticleId></ArticleIdList></Reference><Reference><Citation>de Man TJB, Yaffee AQ, Zhu W, Batra D, Alyanak E, Rowe LA, et al. Multispecies Outbreak of Verona Integron-Encoded Metallo-ß-Lactamase-Producing Multidrug Resistant Bacteria Driven by a promiscuous incompatibility Group A/C2 plasmid. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2021;72(3):414–20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10327870</ArticleId><ArticleId IdType="pubmed">32255490</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer A, Assadian O. Survival of microorganisms on inanimate surfaces. Use Biocidal Surfaces for Reduction of Healthcare Acquired Infections. 2014;7–26.</Citation></Reference><Reference><Citation>Wendt C, Wiesenthal B, Dietz E, Rüden H. Survival of Vancomycin-resistant and Vancomycin-susceptible enterococci on dry surfaces. J Clin Microbiol. 1998;36(12):3734–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC105279</ArticleId><ArticleId IdType="pubmed">9817912</ArticleId></ArticleIdList></Reference><Reference><Citation>Benulič K, Pirš M, Couto N, Chlebowicz M, Rossen JWA, Zorec TM, et al. Whole genome sequencing characterization of Slovenian carbapenem-resistant Klebsiella pneumoniae, including OXA-48 and NDM-1 producing outbreak isolates. PLoS ONE. 2020;15(4):e0231503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153892</ArticleId><ArticleId IdType="pubmed">32282829</ArticleId></ArticleIdList></Reference><Reference><Citation>Emeraud C, Birer A, Girlich D, Jousset AB, Creton E, Naas T, et al. Polyclonal dissemination of OXA-232 carbapenemase-producing Klebsiella pneumoniae, France, 2013–2021. Emerg Infect Dis. 2022;28(11):2304–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9622251</ArticleId><ArticleId IdType="pubmed">36286195</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludden C, Lötsch F, Alm E, Kumar N, Johansson K, Albiger B et al. Cross-border spread of bla(NDM-1)- and bla(OXA-48)-positive Klebsiella pneumoniae: a European collaborative analysis of whole genome sequencing and epidemiological data, 2014 to 2019. Euro Surveill. 2020;25(20).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262493</ArticleId><ArticleId IdType="pubmed">32458791</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandfort M, Hans JB, Fischer MA, Reichert F, Cremanns M, Eisfeld J et al. Increase in NDM-1 and NDM-1/OXA-48-producing Klebsiella pneumoniae in Germany associated with the war in Ukraine, 2022. Euro Surveill. 2022;27(50).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9808319</ArticleId><ArticleId IdType="pubmed">36695468</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson DJ, Chen LF, Weber DJ, Moehring RW, Lewis SS, Triplett PF, et al. Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the benefits of enhanced terminal room disinfection study): a cluster-randomised, multicentre, crossover study. Lancet. 2017;389(10071):805–14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5935446</ArticleId><ArticleId IdType="pubmed">28104287</ArticleId></ArticleIdList></Reference><Reference><Citation>Thom KA, Rock C, Robinson GL, Reisinger HS, Baloh J, Li S, et al. Direct gloving vs Hand Hygiene before donning gloves in adherence to hospital infection Control practices: a Cluster Randomized Clinical Trial. JAMA Netw Open. 2023;6(10):e2336758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10603500</ArticleId><ArticleId IdType="pubmed">37883088</ArticleId></ArticleIdList></Reference><Reference><Citation>Stiefel U, Cadnum JL, Eckstein BC, Guerrero DM, Tima MA, Donskey CJ. Contamination of hands with methicillin-resistant Staphylococcus aureus after contact with environmental surfaces and after contact with the skin of colonized patients. Infect Control Hosp Epidemiol. 2011;32(2):185–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21460476</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris AD, Pineles L, Belton B, Johnson JK, Shardell M, Loeb M, et al. Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial. JAMA. 2013;310(15):1571–80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4026208</ArticleId><ArticleId IdType="pubmed">24097234</ArticleId></ArticleIdList></Reference><Reference><Citation>BETCO and Environzyme. Betco® Launches New Probiotic Cleaning Program and Products [ https://www.betco.com/about/betco-news/blog/2022/10/07/betco-launches-new-probiotic-cleaning-program-and-products</Citation></Reference><Reference><Citation>Chrisal HEIQ. Synbiotics. 2023 [ https://www.heiq.com/inside-heiq/heiq-chrisal/</Citation></Reference><Reference><Citation>Ingenious Probiotics. Denaa + Sanitary Cleaner - Probiotic commercial cleaning [ https://ingenious-probiotics.com/wp-content/uploads/2021/05/DENAA-Probiotic-Commercial-Cleaning-Range-05.21.pdf</Citation></Reference><Reference><Citation>Novozymes. Microvia TM Pro [ https://www.novozymes.com/en/products/microbial-cleaning/microvia-pro</Citation></Reference><Reference><Citation>Pollet Cleaning and Hygiene Solutions. Probiotics - PolVita [ https://en.pollet.eu/about-us/expertise/probiotics/</Citation></Reference><Reference><Citation>Caselli E, Antonioli P, Mazzacane S. Safety of probiotics used for hospital environmental sanitation. J Hosp Infect. 2016;94(2):193–4.</Citation><ArticleIdList><ArticleId IdType="pubmed">27436618</ArticleId></ArticleIdList></Reference><Reference><Citation>Caselli E, D’Accolti M, Vandini A, Lanzoni L, Camerada MT, Coccagna M, et al. Impact of a probiotic-based cleaning intervention on the Microbiota Ecosystem of the Hospital surfaces: Focus on the Resistome Remodulation. PLoS ONE. 2016;11(2):e0148857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4757022</ArticleId><ArticleId IdType="pubmed">26886448</ArticleId></ArticleIdList></Reference><Reference><Citation>Kommission für Krankenhaushygiene. Und Infektionsprävention (KRINKO) beim Robert Koch-Institut. Anforderungen an die Hygiene Bei Der Reinigung Und Desinfektion Von Flächen: Empfehlung Der Kommission für krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022;65(10):1074–115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9521013</ArticleId><ArticleId IdType="pubmed">36173419</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald D, Ackermann G, Khailova L, Baird C, Heyland D, Kozar R et al. Extreme Dysbiosis Microbiome Crit Illn mSphere. 2016;1(4).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5007431</ArticleId><ArticleId IdType="pubmed">27602409</ArticleId></ArticleIdList></Reference><Reference><Citation>Klassert TE, Zubiria-Barrera C, Denkel L, Neubert R, Schneegans A, Kulle A, et al. Skin dysbiosis and loss of microbiome site specificity in critically ill patients. Microbiol Spectr. 2024;12(3):e0307823.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10913461</ArticleId><ArticleId IdType="pubmed">38353551</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold C. Rethinking sterile: the hospital microbiome. Environ Health Perspect. 2014;122(7):A182–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4080534</ArticleId><ArticleId IdType="pubmed">24983914</ArticleId></ArticleIdList></Reference><Reference><Citation>Christoff AP, Sereia AF, Hernandes C, de Oliveira LF. Uncovering the hidden microbiota in hospital and built environments: new approaches and solutions. Exp Biol Med (Maywood). 2019;244(6):534–42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6547007</ArticleId><ArticleId IdType="pubmed">30616384</ArticleId></ArticleIdList></Reference><Reference><Citation>Klassert TE, Zubiria-Barrera C, Neubert R, Stock M, Schneegans A, López M, et al. Comparative analysis of surface sanitization protocols on the bacterial community structures in the hospital environment. Clin Microbiol Infect. 2022;28(8):1105–1112.</Citation><ArticleIdList><ArticleId IdType="pubmed">35272014</ArticleId></ArticleIdList></Reference><Reference><Citation>Dancer SJ. Hospital cleaning: past, present, and future. Antimicrob Resist Infect Control. 2023;12(1):80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10464435</ArticleId><ArticleId IdType="pubmed">37608396</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibbing ME, Fuqua C, Parsek MR, Peterson SB. Bacterial competition: surviving and thriving in the microbial jungle. Nat Rev Microbiol. 2010;8(1):15–25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2879262</ArticleId><ArticleId IdType="pubmed">19946288</ArticleId></ArticleIdList></Reference><Reference><Citation>Abt MC, Pamer EG. Commensal bacteria mediated defenses against pathogens. Curr Opin Immunol. 2014;29:16–22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4132187</ArticleId><ArticleId IdType="pubmed">24727150</ArticleId></ArticleIdList></Reference><Reference><Citation>Leistner R, Kohlmorgen B, Brodzinski A, Schwab F, Lemke E, Zakonsky G, Gastmeier P. Environmental cleaning to prevent hospital-acquired infections on non-intensive care units: a pragmatic, single-centre, cluster randomized controlled, crossover trial comparing soap-based, disinfection and probiotic cleaning. EClinicalMedicine. 2023;59:101958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10113752</ArticleId><ArticleId IdType="pubmed">37089619</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarricone R, Rognoni C, Arnoldo L, Mazzacane S, Caselli E. A probiotic-based Sanitation System for the Reduction of Healthcare Associated Infections and Antimicrobial resistances: a Budget Impact Analysis. Pathogens. 2020;9(6).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7350316</ArticleId><ArticleId IdType="pubmed">32585922</ArticleId></ArticleIdList></Reference><Reference><Citation>Caselli E, Arnoldo L, Rognoni C, D’Accolti M, Soffritti I, Lanzoni L, et al. Impact of a probiotic-based hospital sanitation on antimicrobial resistance and HAI-associated antimicrobial consumption and costs: a multicenter study. Infect Drug Resist. 2019;12:501–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6398408</ArticleId><ArticleId IdType="pubmed">30881055</ArticleId></ArticleIdList></Reference><Reference><Citation>Caselli E, Brusaferro S, Coccagna M, Arnoldo L, Berloco F, Antonioli P, et al. Reducing healthcare-associated infections incidence by a probiotic-based sanitation system: a multicentre, prospective, intervention study. PLoS ONE. 2018;13(7):e0199616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6042698</ArticleId><ArticleId IdType="pubmed">30001345</ArticleId></ArticleIdList></Reference><Reference><Citation>Caselli E, D’Accolti M, Soffritti I, Lanzoni L, Bisi M, Volta A, et al. An innovative strategy for the effective reduction of MDR pathogens from the nosocomial environment. Adv Exp Med Biol. 2019;1214:79–91.</Citation><ArticleIdList><ArticleId IdType="pubmed">31321750</ArticleId></ArticleIdList></Reference><Reference><Citation>Soffritti I, D’Accolti M, Cason C, Lanzoni L, Bisi M, Volta A, et al. Introduction of probiotic-based sanitation in the Emergency Ward of a children’s Hospital during the COVID-19 pandemic. Infect Drug Resist. 2022;15:1399–410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8978905</ArticleId><ArticleId IdType="pubmed">35386291</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandini A, Temmerman R, Frabetti A, Caselli E, Antonioli P, Balboni PG, et al. Hard surface biocontrol in hospitals using microbial-based cleaning products. PLoS ONE. 2014;9(9):e108598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4178175</ArticleId><ArticleId IdType="pubmed">25259528</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Marzooq F, Bayat SA, Sayyar F, Ishaq H, Nasralla H, Koutaich R, Kawas SA. Can probiotic cleaning solutions replace chemical disinfectants in dental clinics? Eur J Dent. 2018;12(4):532–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6178676</ArticleId><ArticleId IdType="pubmed">30369799</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauci Vl, Costa G, Anastasi F, Facciolà A, Grillo O, Squeri R. An innovative approach to hospital sanitization using probiotics: in vitro and field trials. J Microb Biochem Technol. 2015;7:3</Citation></Reference><Reference><Citation>Nelson SW, Hardison RL, Limmer R, Marx J, Taylor BM, James RR et al. Efficacy of detergent-based cleaning and wiping against SARS-CoV-2 on high-touch surfaces. Lett Appl Microbiol. 2023;76(3).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11417498</ArticleId><ArticleId IdType="pubmed">36906280</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastmeier P, Brunkhorst F, Schrappe M, Kern W, Geffers C. [How many nosocomial infections are avoidable?]. Dtsch Med Wochenschr. 2010;135(3):91–3.</Citation><ArticleIdList><ArticleId IdType="pubmed">20077383</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber PW, Sax H, Wolfensberger A, Clack L, Kuster SP. The preventable proportion of healthcare-associated infections 2005–2016: systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2018;39(11):1277–95.</Citation><ArticleIdList><ArticleId IdType="pubmed">30234463</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Accolti M, Soffritti I, Bini F, Mazziga E, Arnoldo L, Volta A et al. Potential Use of a Combined Bacteriophage-Probiotic Sanitation System to Control Microbial Contamination and AMR in Healthcare Settings: A Pre-Post Intervention Study. Int J Mol Sci. 2023;24(7).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10095405</ArticleId><ArticleId IdType="pubmed">37047510</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Accolti M, Soffritti I, Bini F, Mazziga E, Cason C, Comar M, et al. Shaping the subway microbiome through probiotic-based sanitation during the COVID-19 emergency: a pre-post case-control study. Microbiome. 2023;11(1):64–83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10060134</ArticleId><ArticleId IdType="pubmed">36991513</ArticleId></ArticleIdList></Reference><Reference><Citation>Dancer SJ. Mopping up hospital infection. J Hosp Infect. 1999;43(2):85–100.</Citation><ArticleIdList><ArticleId IdType="pubmed">10549308</ArticleId></ArticleIdList></Reference><Reference><Citation>Dancer SJ. Importance of the environment in meticillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning. Lancet Infect Dis. 2008;8(2):101–13.</Citation><ArticleIdList><ArticleId IdType="pubmed">17974481</ArticleId></ArticleIdList></Reference><Reference><Citation>Dancer SJ. Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination. Clin Microbiol Rev. 2014;27(4):665–90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4187643</ArticleId><ArticleId IdType="pubmed">25278571</ArticleId></ArticleIdList></Reference><Reference><Citation>Dancer SJ. Dos and don’ts for hospital cleaning. Curr Opin Infect Dis. 2016;29(4):415–23.</Citation><ArticleIdList><ArticleId IdType="pubmed">27272734</ArticleId></ArticleIdList></Reference><Reference><Citation>Dancer SJ. How do we assess hospital cleaning? A proposal for microbiological standards for surface hygiene in hospitals. J Hosp Infect. 2004;56(1):10–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7134512</ArticleId><ArticleId IdType="pubmed">14706265</ArticleId></ArticleIdList></Reference><Reference><Citation>Dancer SJ, White LF, Lamb J, Girvan EK, Robertson C. Measuring the effect of enhanced cleaning in a UK hospital: a prospective cross-over study. BMC Med. 2009;7:28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700808</ArticleId><ArticleId IdType="pubmed">19505316</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters A, Schmid MN, Parneix P, Lebowitz D, de Kraker M, Sauser J, et al. Impact of environmental hygiene interventions on healthcare-associated infections and patient colonization: a systematic review. Antimicrob Resist Infect Control. 2022;11(1):38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8857881</ArticleId><ArticleId IdType="pubmed">35183259</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinke R, Meyer B, Frei R, Passweg J, Widmer AF. Equal efficacy of glucoprotamin and an aldehyde product for environmental disinfection in a hematologic transplant unit: a prospective crossover trial. Infect Control Hosp Epidemiol. 2012;33(11):1077–80.</Citation><ArticleIdList><ArticleId IdType="pubmed">23041803</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu H, Johani K, Gosbell IB, Jacombs AS, Almatroudi A, Whiteley GS, et al. Intensive care unit environmental surfaces are contaminated by multidrug-resistant bacteria in biofilms: combined results of conventional culture, pyrosequencing, scanning electron microscopy, and confocal laser microscopy. J Hosp Infect. 2015;91(1):35–44.</Citation><ArticleIdList><ArticleId IdType="pubmed">26187533</ArticleId></ArticleIdList></Reference><Reference><Citation>Vickery K, Deva A, Jacombs A, Allan J, Valente P, Gosbell IB. Presence of biofilm containing viable multiresistant organisms despite terminal cleaning on clinical surfaces in an intensive care unit. J Hosp Infect. 2012;80(1):52–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">21899921</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy K, Sunnucks K, Gil H, Shabir S, Trampari E, Hawkey P, Webber M. Increased usage of Antiseptics is Associated with reduced susceptibility in clinical isolates of Staphylococcus aureus. mBio. 2018;9(3).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5974466</ArticleId><ArticleId IdType="pubmed">29844113</ArticleId></ArticleIdList></Reference><Reference><Citation>Htun HL, Hon PY, Holden MTG, Ang B, Chow A. Chlorhexidine and octenidine use, carriage of qac genes, and reduced antiseptic susceptibility in methicillin-resistant Staphylococcus aureus isolates from a healthcare network. Clin Microbiol Infect. 2019;25(9):1154.e1-.e7.</Citation><ArticleIdList><ArticleId IdType="pubmed">30625411</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschudin-Sutter S, Frei R, Kampf G, Tamm M, Pflimlin E, Battegay M, Widmer AF. Emergence of glutaraldehyde-resistant Pseudomonas aeruginosa. Infect Control Hosp Epidemiol. 2011;32(12):1173–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22080655</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuanchuen R, Beinlich K, Hoang TT, Becher A, Karkhoff-Schweizer RR, Schweizer HP. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob Agents Chemother. 2001;45(2):428–32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC90308</ArticleId><ArticleId IdType="pubmed">11158736</ArticleId></ArticleIdList></Reference><Reference><Citation>Widmer AE, Frei R. Antimicrobial activity of glucoprotamin: a clinical study of a new disinfectant for instruments. Infect Control Hosp Epidemiol. 2003;24(10):762–4.</Citation><ArticleIdList><ArticleId IdType="pubmed">14587939</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Accolti M, Soffritti I, Piffanelli M, Bisi M, Mazzacane S, Caselli E. Efficient removal of hospital pathogens from hard surfaces by a combined use of bacteriophages and probiotics: potential as sanitizing agents. Infect Drug Resist. 2018;11:1015–26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6071622</ArticleId><ArticleId IdType="pubmed">30104889</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Accolti M, Soffritti I, Bonfante F, Ricciardi W, Mazzacane S, Caselli E. Potential of an Eco-sustainable Probiotic-Cleaning Formulation in reducing infectivity of enveloped viruses. Viruses. 2021;13(11).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8617880</ArticleId><ArticleId IdType="pubmed">34835033</ArticleId></ArticleIdList></Reference><Reference><Citation>Neidhöfer C, Rathore K, Parčina M, Sieber MA. ESKAPEE Pathogen Biofilm Control on surfaces with Probiotic Lactobacillaceae and Bacillus species. Antibiot (Basel). 2023;12(5).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10215598</ArticleId><ArticleId IdType="pubmed">37237774</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone W, Tolmay J, Tucker K, Wolfaardt GM. Disinfectant, soap or Probiotic Cleaning? Surface Microbiome Diversity and Biofilm Competitive Exclusion. Microorganisms. 2020;8(11).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7694204</ArticleId><ArticleId IdType="pubmed">33158159</ArticleId></ArticleIdList></Reference><Reference><Citation>Regulations of the European parliament and of the council on detergents and surfactants, amending Regulation (EU) 2019/1020 and repealing Regulation (EC) No 648/2004. (2024).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>